Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 2, 2025Kocaeli Üniversitesi Sağlık Bilimleri DergisiOpen Access

Prognostic Significance of Neutrophil/Lymphocyte Ratio and SOFA Score in Patients with Chronic Obstructive Pulmonary Disease Followed in Intensive Care Unit

View Full Paper
Ask AI
Bookmark
Share

Authors

GCGüzin CeranOÇOğuzhan ÇamurECEmre Ceyhan

Discussion

Loading...

Member takes

Overview

Retrospective cohort study explores mortality prediction using NLR and SOFA score in COPD patients, indicating significant associations.

Key Points

  • Increased neutrophil/lymphocyte ratio and SOFA score are linked to higher mortality in COPD patients in ICU.
  • Logistic regression analysis showed a significant β coefficient for NLR (0.014419, p=0.0383) and SOFA score (0.382920, p=0.001).
  • The study involved 259 COPD patients over 18 years old admitted to the ICU for assessment over two years.
  • Findings emphasize the value of inflammatory biomarkers and scoring systems in predicting mortality in COPD cases.

Cite This Study

Ceran et al. (2025) studied this question.

synapsesocial.com/papers/68de84bb5b556a9128e1babbhttps://doi.org/10.30934/kusbed.1710873
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neutrophil-to-Lymphocyte Ratio (NLR) as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS cohort2025
  2. 2Correlations Between Inflammatory Biomarkers and COPD Severity in a Real-Life Setting2025
  3. 3Relationship between eosinopenia and neutrophil-lymphocyte ratio with sepsis-related mortality in the intensive care unit.2025
  4. 4Multiple organ scoring systems for predicting in-hospital mortality of sepsis patients in the intensive care unit2025
  5. 5Non-linear association between neutrophil-to-lymphocyte ratio and 90-day mortality in patients with pneumonia receiving glucocorticoids alone or in combination with other immunosuppressants: A retrospective cohort study2025